Home › NDC Lookup › RxCUI directory › RxCUI 1716077

Buprenorphine 0.075 MG Buccal Film — RxCUI 1716077

RxNorm drug concept · Semantic clinical drug
RxCUI 1716077 Semantic clinical drug · SCD ● Current RxNorm concept 7 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1716077
Official nameBuprenorphine 0.075 MG Buccal Film
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbuprenorphine HCl 75 MCG Buccal Film
FDA products mapped7
Package NDCs mapped7
Reported Medicaid activity (SDUD)55,215 prescriptions · 40 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Buprenorphine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No, the buprenorphine transdermal patch is specifically for managing severe, persistent pain that needs continuous, around-the-clock treatment over an extended period. It's prescri...
  • What is this patch actually for — is it for addiction treatment?
  • Each patch is worn on your skin for 7 days before being swapped out. You apply it to clean, dry, intact skin on your upper outer arm, upper chest, upper back, or side of the chest....
  • How do I apply the patch, and how long does each one last?
📖 Read our full Buprenorphine Transdermal Patch guide →

🕸️ Concept Web — How Buprenorphine 0.075 MG Buccal Film Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Buprenorphine 0.075 MG Buccal Film RxCUI 1716077

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Buprenorphine 1819
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Belbuca 1716058
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Buprenorphine Buccal Film 1716056
    • Buprenorphine Buccal Product 1716055
    • Buprenorphine Oral Product 1151362
    • Buprenorphine Buccal Film [Belbuca] 1716060
    • Belbuca Buccal Product 1716061
    • Belbuca Oral Product 1716062
    • Buccal Film 858080
    • Buccal Product 1294701
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Buprenorphine 0.075 MG SCDC · 1716076
  • Buprenorphine Buccal Film SCDF · 1716056
  • Buprenorphine Buccal Product SCDG · 1716055
  • Buprenorphine Oral Product SCDG · 1151362

Brand-Name Concepts

  • Buprenorphine 0.075 MG Buccal Film [Belbuca] SBD · 1716079
  • Buprenorphine 0.075 MG [Belbuca] SBDC · 1716078
  • Buprenorphine Buccal Film [Belbuca] SBDF · 1716060
  • Belbuca Buccal Product SBDG · 1716061
  • Belbuca Oral Product SBDG · 1716062
  • Belbuca BN · 1716058

📦 FDA Products & Package NDCs

7 products · 7 package NDCs
7 package NDCs map to RxCUI 1716077 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59385-0021-60 60 POUCH in 1 CARTON (59385-021-60) / 1 FILM, SOLUBLE in 1... BELBUCA BioDelivery Sciences International Inc 2017-09-01
59385-0022-60 60 POUCH in 1 CARTON (59385-022-60) / 1 FILM, SOLUBLE in 1... BELBUCA BioDelivery Sciences International Inc 2017-10-01
59385-0023-60 60 POUCH in 1 CARTON (59385-023-60) / 1 FILM, SOLUBLE in 1... BELBUCA BioDelivery Sciences International Inc 2017-09-01
59385-0024-60 60 POUCH in 1 CARTON (59385-024-60) / 1 FILM, SOLUBLE in 1... BELBUCA BioDelivery Sciences International Inc 2017-08-21
59385-0025-60 60 POUCH in 1 CARTON (59385-025-60) / 1 FILM, SOLUBLE in 1... BELBUCA BioDelivery Sciences International Inc 2017-08-24
59385-0026-60 60 POUCH in 1 CARTON (59385-026-60) / 1 FILM, SOLUBLE in 1... BELBUCA BioDelivery Sciences International Inc 2017-10-01
59385-0027-60 60 POUCH in 1 CARTON (59385-027-60) / 1 FILM, SOLUBLE in 1... BELBUCA BioDelivery Sciences International Inc 2017-08-11
Observed labelers: BioDelivery Sciences International Inc (7) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.